Search - tctmd.com

Displaying 321 - 340 of 461

Sort: Relevancy | Date

News Daily News

Obesity Prevalence Triples in China Over 10-Year Span

Michael O'Riordan

October 28, 2019

News Daily News

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

L.A. McKeown

October 23, 2019

News Daily News

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Caitlin E. Cox

October 21, 2019

News Daily News

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Michael O'Riordan

October 09, 2019

News Conference News TCT 2019

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

L.A. McKeown

September 25, 2019

News Conference News HFSA 2019

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

L.A. McKeown

September 24, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

News Conference News ESC 2019

Community-Level Salt-Swapping Strategy Pays Dividends in Peru

Todd Neale

September 09, 2019

News Conference News ESC 2019

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

Yael L. Maxwell

September 06, 2019

News Conference News ESC 2019

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

Michael O'Riordan

September 05, 2019

News Conference News ESC 2019

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Michael O'Riordan

September 04, 2019

News Conference News ESC 2019

Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

Michael O'Riordan

September 02, 2019

News Conference News ESC 2019

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

Yael L. Maxwell

September 01, 2019

News Daily News

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Todd Neale

August 19, 2019

News Features

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Marcus A. Banks

August 15, 2019

News Daily News

Ideal CV Health at Age 50 Foretells Lower Risk of Later Dementia

Marcus A. Banks

August 12, 2019

News Daily News

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Marcus A. Banks

July 12, 2019

News Daily News

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

Michael O'Riordan

July 09, 2019

News Daily News

To Battle CVD in China, the ‘Healthcare Pyramid’ Must Be Flipped

L.A. McKeown

June 25, 2019

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

Advertisement

Obesity Prevalence Triples in China Over 10-Year Span

Nighttime Hypertension Drug Dosing May Reduce Risk of CVD

Disparate US Trends in Early CVD Deaths Speak to Need for Targeted Prevention

Dramatic Swings in Household Income Linked to CVD Risk: ARIC

Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety

Old Dog, New Tricks? HOMAGE Hints at Role for Spironolactone in HF Prevention

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

Community-Level Salt-Swapping Strategy Pays Dividends in Peru

Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories

New ESC Diabetes Guidelines Focus on CVD Prevention, New Drug Classes, and Low LDL

New PURE Insights: CVD Deaths Dip in Rich Nations Amid Risk-Factor Surprises

Lifelong Exposure to Lower LDL and BP Linked With Big Reduction in CVD Events

CONDI-2/ERIC-PPCI Puts the Kibosh on Ischemic Conditioning in STEMI

FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure

Wearables Under the Microscope: How New Tech Will Disrupt Patient-Physician Dynamics

Ideal CV Health at Age 50 Foretells Lower Risk of Later Dementia

Sudden, ‘Biologically Implausible’ Rise in Valsartan-Linked Neoplasms After 2018 Recall

Most Supplements and Diets Don’t Lower CVD or Mortality Risks

To Battle CVD in China, the ‘Healthcare Pyramid’ Must Be Flipped

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content